IKT:NASDAQ
Inhibikase Therapeutics Inc
US$2,06
arrow_upward
+1,73%(+0,035) 1D
US$2,06
0,00% (0,00)
bedtimeAfter hours
Closed: 30 ກ.ຍ., 16 ໂມງ 0 ນາທີ 01 ວິນາທີ GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for IKT...
Open
US$2,03
High
US$2,08
Low
US$1,99
Mkt. cap
286,75 ລ້ານ
Avg. vol.
515,79 ພັນ
Volume
579,46 ພັນ
52-wk high
US$2,61
52-wk low
US$1,33
EPS
US$-0,44
Beta
0,95
Shares outstanding
139,54 ລ້ານ
No. of employees
35
Open
US$2,03
High
US$2,08
Low
US$1,99
Mkt. cap
286,75 ລ້ານ
Avg. vol.
515,79 ພັນ
Volume
579,46 ພັນ
52-wk high
US$2,61
52-wk low
US$1,33
EPS
US$-0,44
Beta
0,95
Shares outstanding
139,54 ລ້ານ
No. of employees
35
News stories
From web sources and news partners
Kalkine Media
·
33 ນາທີກ່ອນ
BVF Partners Reveals 5.6% Ownership Stake in Stoke Therapeutics Inc. (NASDAQ:STOK)
Seeking Alpha
·
30 ນາທີກ່ອນ
Lower-Than-Expected PCE Data Failed To Help Markets (SP500)
Barchart.com
·
54 ນາທີກ່ອນ
What You Need To Know Ahead of Nasdaq's Earnings Release
Yahoo Finance
·
5 ຊົ່ວໂມງກ່ອນ
Blood Cancer United Rings Nasdaq Closing Bell to Celebrate More Time for Patients
About Inhibikase Therapeutics Inc
CEO-
Employees35
Founded2008
HeadquartersWilmington, ເດລາແວ, ສະຫະລັດ
SectorBiotechnology
Websiteinhibikase.com